Abstract
Pemphigoid and Pemphigus are both blistering autoimmune skin diseases that can have systemic manifestations. Little information exists on the outcomes of COVID patients with these blistering diseases, so the goal was to investigate the impact of both on COVID outcomes. A retrospective cohort study was done using TriNetX, a federated real time database of 63 million records. COVID patient cohorts were identified by validated ICD-10 and serology codes per CDC guidelines from 1/20/2020 to 2/5/2021.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
